- Stocks
- Healthcare
- NASDAQ: DTIL

Price (delayed)

$9.39

Market cap

$539.74M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.9

Enterprise value

$356.34M

Precision Biosciences's revenue has increased by 41% YoY and by 39% from the previous quarter

Precision Biosciences's gross profit has increased by 41% YoY and by 39% from the previous quarter

Precision Biosciences's quick ratio has decreased by 50% YoY but it has increased by 43% QoQ

The company's equity fell by 49% YoY but it rose by 32% QoQ

What are the main financial stats of DTIL

Market
Valuations
Earnings

Shares outstanding

57.48M

Market cap

$539.74M

Enterprise value

$356.34M

Price to earnings (P/E)

N/A

Price to book (P/B)

9.1

Price to sales (P/S)

15.81

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

10.59

Revenue

$33.64M

EBIT

-$100.86M

EBITDA

-$90.97M

Free cash flow

$1.54M

Per share
Balance sheet
Liquidity

EPS

-$1.9

Free cash flow per share

$0.03

Book value per share

$1.03

Revenue per share

$0.59

TBVPS

$4.61

Total assets

$262.32M

Total liabilities

$203.49M

Debt

$10.06M

Equity

$58.82M

Working capital

$155.34M

Debt to equity

0.17

Current ratio

3.43

Quick ratio

3.33

Net debt/EBITDA

2.02

Margins
Efficiency
Dividend

EBITDA margin

-270.5%

Gross margin

100%

Net margin

-299.9%

Operating margin

-300.5%

Return on assets

-52.7%

Return on equity

-159.7%

Return on invested capital

-383.9%

Return on capital employed

-50.8%

Return on sales

-299.9%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Precision Biosciences stock price performed over time

Intraday

-1.16%

1 week

16.36%

1 month

7.07%

1 year

20.54%

YTD

12.59%

QTD

-9.28%

How have Precision Biosciences's revenue and profit performed over time

Revenue

$33.64M

Gross profit

$33.64M

Operating income

-$101.07M

Net income

-$100.86M

Gross margin

100%

Net margin

-299.9%

Precision Biosciences's revenue has increased by 41% YoY and by 39% from the previous quarter

Precision Biosciences's gross profit has increased by 41% YoY and by 39% from the previous quarter

The operating margin is up by 34% since the previous quarter and by 25% year-on-year

DTIL's net margin is up by 33% QoQ and by 19% YoY

What is Precision Biosciences's growth rate over time

What is Precision Biosciences stock price valuation

P/E

N/A

P/B

9.1

P/S

15.81

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

10.59

DTIL's EPS is down by 13% year-on-year but it is up by 9% since the previous quarter

The company's equity fell by 49% YoY but it rose by 32% QoQ

DTIL's P/B is 21% above its last 4 quarters average of 7.5

Precision Biosciences's revenue has increased by 41% YoY and by 39% from the previous quarter

The P/S is 12% lower than the last 4 quarters average of 18.0

How efficient is Precision Biosciences business performance

Precision Biosciences's return on equity has shrunk by 165% YoY and by 13% QoQ

Precision Biosciences's ROA has decreased by 47% YoY but it has increased by 13% from the previous quarter

The return on invested capital has declined by 41% year-on-year and by 21% since the previous quarter

DTIL's ROS is up by 33% since the previous quarter and by 19% year-on-year

What is DTIL's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for DTIL.

How did Precision Biosciences financials performed over time

Precision Biosciences's total assets is 29% more than its total liabilities

The total liabilities has soared by 105% year-on-year and by 92% since the previous quarter

Precision Biosciences's total assets has soared by 75% from the previous quarter and by 22% YoY

DTIL's debt is 83% lower than its equity

The debt to equity has surged by 70% year-on-year but it has declined by 29% since the previous quarter

The company's equity fell by 49% YoY but it rose by 32% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.